Likes	Subject	Older
	Up $18+ or >13% is my idea of		vinmantoo	02/16/23 9:01 PM
	SGEN $139.77 +$1.76 a share (+1.275%)		MiamiGent	01/26/23 10:32 AM
	Re: MiamiGent post# 631252		MiamiGent	01/26/23 10:12 AM
	Good morning Larry.		MiamiGent	01/26/23 7:02 AM
	SGEN Steady climb now on a red day.		MiamiGent	01/24/23 12:29 PM
	HUGE gains for $SGEN shares down the road		Protocola	07/12/22 3:51 PM
	Astellas Pharma, Seagen Get CHMP Positive Opinion for Padcev		Phosphene	01/04/22 8:48 PM
	Seagen and Astellas’ Padcev for Urothelial Cancer		Phosphene	08/18/21 8:05 PM
	Seagen, RemeGen Ink $2.6B License Agreement for Anti-HER2		Phosphene	08/18/21 8:03 PM
	EMA Committee Recommends Approval for Seagen's Tukysa in		Phosphene	12/13/20 7:52 AM
	BREAKING NEWS: $SGEN 3 Top Growth Stocks to		whytestocks	11/14/20 12:30 PM
	Seattle Genetics (SGEN) to Release Earnings on 10/29/20		Phosphene	10/22/20 10:38 AM
	As a longtime SGEN shareholder, this price rise		vinmantoo	10/13/20 1:58 PM
	Seattle Genetics shortens name to Seagen, dropping local		Phosphene	10/13/20 9:52 AM
	Merck & Co to buy $1bn stake in		Phosphene	10/07/20 12:00 PM
	Seattle Genetics plans manufacturing expansion with cash from		Phosphene	09/28/20 12:05 PM
	Seattle Genetics and Genmab Present Data from Tisotumab		Phosphene	09/21/20 2:22 PM
	Astellas, Seattle Genetics' Padcev bladder cancer trial stops		Phosphene	09/18/20 11:58 AM
	Breaking News: $SGEN Merck Inks Multibillion-Dollar Deal With		whytestocks	09/14/20 10:16 PM
	NEWS: $SGEN Seattle Genetics and Merck Announce Two		whytestocks	09/14/20 10:00 PM
	The Baker Brothers have 27% ownership.		Phosphene	08/30/20 11:08 PM
	Seattle Genetics to Receive Milestone Payment Under ADC		Phosphene	08/30/20 10:18 PM
	Seattle Genetics Appoints Ted W. Love, M.D., to		Phosphene	08/22/20 12:48 PM
	Hmmm maybe US deny for now		T695	08/19/20 3:57 PM
	Seattle Genetics gets FDA approval for breast cancer		Phosphene	04/17/20 8:35 PM
	How a Seattle Genetics cancer drug could help		Phosphene	04/13/20 7:52 AM
	https://mobile.twitter.com/SeattleGenetics/status/1220436036997660672		mellow fellow	01/23/20 5:13 PM
	Seattle Genetics Achieves Milestone Following European Commission Approval		mellow fellow	01/21/20 5:33 PM
	$SGEN bears are running https://news.squeezereport.com/short-squeeze		whytestocks	11/12/19 11:25 AM
	Seattle Genetics will receive an upfront payment and		Phosphene	11/06/19 12:16 PM
	News: $SGEN Seattle Genetics Announces Positive Topline Results		whytestocks	10/21/19 12:45 PM
	News: $SGEN Here's Why Seattle Genetics Stock Jumped		whytestocks	09/30/19 2:00 PM
	News: $SGEN Initial Results from MOUNTAINEER Trial Show		whytestocks	09/29/19 9:10 AM
	News: $SGEN Seattle Genetics and Astellas Announce Results		whytestocks	09/28/19 8:00 AM
	SGEN DAY		PennyStock Alert	09/16/19 9:06 AM
	“The current standard of care for initial treatment		crudeoil24	11/16/18 3:00 PM
	SGEN is a great $$$$$ opportunity.		crudeoil24	11/16/18 2:52 PM
	Also, Seattle pounded the Packers last night!		crudeoil24	11/16/18 2:52 PM
	Agree!		crudeoil24	11/16/18 2:51 PM
	https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626079.htm		crudeoil24	11/16/18 2:50 PM
	Boom! > FDA approves Adcetris > SGEN		crudeoil24	11/16/18 2:31 PM
	SGEN is looking to bust $70. I think		46er	06/12/18 3:20 PM
	$SGEN OVER BOUGHT. RETRACE TO $20 imo coming		BottomBounce	11/29/17 12:44 AM
	There's a whole little flock of new collaborations		shub	10/11/17 2:25 PM
	It sure is an incoherent and dispersed bunch		shub	10/03/17 3:39 PM
	Thanks for the tips. I'll sure take a		cdaniel394	10/03/17 3:20 PM
	CD: Took a nibble of AMFE but it		shub	10/03/17 3:17 PM
	Thanks C Daniel:		shub	10/03/17 2:44 PM
	Thank you. Just had a friends brother who		cdaniel394	10/03/17 2:42 PM
	With all their drugs in testing or trials,		shub	10/03/17 2:41 PM
Likes	Subject	Older

Older

vinmantoo

02/16/23 9:01 PM

Up $18+ or >13% is my idea of

MiamiGent

01/26/23 10:32 AM

SGEN $139.77 +$1.76 a share (+1.275%)

MiamiGent

01/26/23 10:12 AM

Re: MiamiGent post# 631252

MiamiGent

01/26/23 7:02 AM

Good morning Larry.

MiamiGent

01/24/23 12:29 PM

SGEN Steady climb now on a red day.

Protocola

07/12/22 3:51 PM

HUGE gains for $SGEN shares down the road

Phosphene

01/04/22 8:48 PM

Astellas Pharma, Seagen Get CHMP Positive Opinion for Padcev

Phosphene

08/18/21 8:05 PM

Seagen and Astellas’ Padcev for Urothelial Cancer

Phosphene

08/18/21 8:03 PM

Seagen, RemeGen Ink $2.6B License Agreement for Anti-HER2

Phosphene

12/13/20 7:52 AM

EMA Committee Recommends Approval for Seagen's Tukysa in

whytestocks

11/14/20 12:30 PM

BREAKING NEWS: $SGEN 3 Top Growth Stocks to

Phosphene

10/22/20 10:38 AM

Seattle Genetics (SGEN) to Release Earnings on 10/29/20

vinmantoo

10/13/20 1:58 PM

As a longtime SGEN shareholder, this price rise

Phosphene

10/13/20 9:52 AM

Seattle Genetics shortens name to Seagen, dropping local

Phosphene

10/07/20 12:00 PM

Merck & Co to buy $1bn stake in

Phosphene

09/28/20 12:05 PM

Seattle Genetics plans manufacturing expansion with cash from

Phosphene

09/21/20 2:22 PM

Seattle Genetics and Genmab Present Data from Tisotumab

Phosphene

09/18/20 11:58 AM

Astellas, Seattle Genetics' Padcev bladder cancer trial stops

whytestocks

09/14/20 10:16 PM

Breaking News: $SGEN Merck Inks Multibillion-Dollar Deal With

whytestocks

09/14/20 10:00 PM

NEWS: $SGEN Seattle Genetics and Merck Announce Two

Phosphene

08/30/20 11:08 PM

The Baker Brothers have 27% ownership.

Phosphene

08/30/20 10:18 PM

Seattle Genetics to Receive Milestone Payment Under ADC

Phosphene

08/22/20 12:48 PM

Seattle Genetics Appoints Ted W. Love, M.D., to

T695

08/19/20 3:57 PM

Hmmm maybe US deny for now

Phosphene

04/17/20 8:35 PM

Seattle Genetics gets FDA approval for breast cancer

Phosphene

04/13/20 7:52 AM

How a Seattle Genetics cancer drug could help

mellow fellow

01/23/20 5:13 PM

https://mobile.twitter.com/SeattleGenetics/status/1220436036997660672

mellow fellow

01/21/20 5:33 PM

Seattle Genetics Achieves Milestone Following European Commission Approval

whytestocks

11/12/19 11:25 AM

$SGEN bears are running https://news.squeezereport.com/short-squeeze

Phosphene

11/06/19 12:16 PM

Seattle Genetics will receive an upfront payment and

whytestocks

10/21/19 12:45 PM

News: $SGEN Seattle Genetics Announces Positive Topline Results

whytestocks

09/30/19 2:00 PM

News: $SGEN Here's Why Seattle Genetics Stock Jumped

whytestocks

09/29/19 9:10 AM

News: $SGEN Initial Results from MOUNTAINEER Trial Show

whytestocks

09/28/19 8:00 AM

News: $SGEN Seattle Genetics and Astellas Announce Results

PennyStock Alert

09/16/19 9:06 AM

SGEN DAY

crudeoil24

11/16/18 3:00 PM

“The current standard of care for initial treatment

crudeoil24

11/16/18 2:52 PM

SGEN is a great $$$$$ opportunity.

crudeoil24

11/16/18 2:52 PM

Also, Seattle pounded the Packers last night!

crudeoil24

11/16/18 2:51 PM

Agree!

crudeoil24

11/16/18 2:50 PM

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626079.htm

crudeoil24

11/16/18 2:31 PM

Boom! > FDA approves Adcetris > SGEN

46er

06/12/18 3:20 PM

SGEN is looking to bust $70. I think

BottomBounce

11/29/17 12:44 AM

$SGEN OVER BOUGHT. RETRACE TO $20 imo coming

shub

10/11/17 2:25 PM

There's a whole little flock of new collaborations

shub

10/03/17 3:39 PM

It sure is an incoherent and dispersed bunch

cdaniel394

10/03/17 3:20 PM

Thanks for the tips. I'll sure take a

shub

10/03/17 3:17 PM

CD: Took a nibble of AMFE but it

shub

10/03/17 2:44 PM

Thanks C Daniel:

cdaniel394

10/03/17 2:42 PM

Thank you. Just had a friends brother who

shub

10/03/17 2:41 PM

With all their drugs in testing or trials,

Older

Seattle Genetics (SGEN)

Followers	24	Posters	59
Posts (Today)	0	Posts (Total)	280
Created	12/09/06	Type	Free
Moderators

http://www.seattlegenetics.com

http://finance.yahoo.com/q/ks?s=SGEN

http://www.form4oracle.com/company?cik=0001060736&ticker=sgen

Seattle Genetics, Inc. operates as a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer, including lymphoma, multiple myeloma, leukemia, and solid tumors. The company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize SGN-40, a humanized monoclonal antibody that is in phase I and phase II clinical development for patients with diffuse large B-cell lymphoma and multiple myeloma. It also has three other proprietary programs in ongoing clinical trials: SGN-33, SGN-35, and SGN-30. The company's SGN-33 is in a phase IIb clinical trial for the patients with acute myeloid leukemia or myelodysplastic syndromes; and SGN-30 and SGN-35 are in phase II clinical trails for the treatment of CD30-positive hematologic malignancies, such as Hodgkin's disease and anaplastic large cell lymphoma. In addition, it developed proprietary antibody-drug conjugate (ADC) technology comprising highly potent synthetic drugs and stable linkers for attaching the drugs to monoclonal antibodies. The company's product candidates also include SGN-70, a humanized anti-CD70 monoclonal antibody with potent effector function and intrinsic cell-killing ability; and SGN-75, which consists of an anti-CD70 monoclonal antibody linked to an auristatin derivative using its proprietary ADC technology. Seattle Genetics has license agreements with Bayer, CuraGen, Progenics, MedImmune, and PDL BioPharma to use its proprietary ADC technology with their monoclonal antibodies; and an ADC co-development agreement with Agensys and Celera Genomics. The company was founded in 1997 and is headquartered in Bothell, Washington
.